| [1] |
Ingham PW. Transducing hedgehog: the story so far[J]. EMBO J, 19 98, 17(13): 3505-11.
|
| [2] |
Maesawa C, Tamura G, Iwaya T, et al. Mutations in the human homologue of the Drosophila patched gene in esophageal squamous cell carcinoma[J]. Genes Chromosomes Cancer, 1998, 21 (3): 276-9.
|
| [3] |
Yang L,Wang LS, Chen XL,et al.Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus[J]. Int J Biochem Mol Biol, 2012, 3(1):46-57.
|
| [4] |
MD Anderson News Release. Scientists Link Two Cancer- Promoting Pathways in Esophageal Cancer [EB/OL]. MD Anderson Cancer Center, 2012-03-19 [2013.10.14].http://www. mdanderson.org/newsroom/news-releases/2012/scientists-linktwo- cancer-promoting-pathways-in-esophageal-cancer.html.
|
| [5] |
Chang D,Wang TY,Li HC,et al.Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China[J]. Dis Esophagus, 20 07,20(6):491-6.
|
| [6] |
Hildebrandt MA,Yang H,Hung MC,et al.Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy[J].J Clin Oncol,2009,27(6):857-71.
|
| [7] |
Luo HS, Jin LL, Tong Q, et al. Effects of AKt inhibitor perifosine on proliferation and apoptosis of esophageal carcinoma cells[J]. Lin Chuang Nei Ke Za Zhi, 2011,28(11):778-80.[ , , ͯǿ, . ¶ ʳ ܰ ϸ ֳ ͵ Ӱ [J]. ٴ ־,2011,28(11):778-80]
|
| [8] |
Song X,Yang JX,Li XC,et al.The relationship of the family history of 61 781 patients with esophageal cancer with two SNPs variability[C]//The tumor epidemiology and etiology of academic conference proceedings, Tianjing: Chinese Anticancer Association,2011:44. [ , ѧ, ˴ , .61 781 ʳ ܰ ʷ 2 SNPs ط [C]//ȫ в ѧ ѧѧ ļ . й Э ,2011:44.]
|
| [9] |
Danielsen SA,Cekaite L,Agesen TH,et al.Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome[J]. PLoS One, 2011, 6(9):e24419.
|
| [10] |
Hou GQ, Lu ZM, Mu X,et al.Activation of mammalian target of rapamycin (mTOR) in esophageal squamous cell carcinona cell line[J]. Zhongguo Zhong Liu,2007,16(4):260-2.[ ,³ , , . ù ذе ź ͨ· ʳ ܰ ϸ ϵ м ״ ̬ о [J]. й ,2007,16(4):260-2.]
|
| [11] |
Hou GQ,Fan TL,Wang LL,et al.Effects of rapamycin on mTOR/p7 S6K signaling pathway and tumor growth in xenografted esophageal squamous cell carcinoma[J]. Zhong Liu,2009,29(6):559-62.[ , , , . ù ض ʳ ۰ ֲ mTOR/p70S6K ź ͨ· Ӱ [J]. ,2009,29(6):559-62.]
|
| [12] |
Sarbassov DD, Ali SM,Sengupta S,et al.Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB[J]. Mol Cell, 20 06, 22(2):159-68.
|
| [13] |
Edinger AL,Linardic CM,Chiang GG, et al.Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells[J]. Cancer Res, 2003. 63(23):8451-60.
|
| [14] |
Liu QW,Fu JH,Yang HX,et al.Identification of EGFR and KRAS mutations in Chinese patients with esophageal squamous cell carcinoma[J]. Dis Esophagus, 2011,[Epub ahead of print].
|
| [15] |
E.F.W.Courrech Staal.Improvement of the multimodality treatment of oesophageal cancer[D]. AMC-UvA,2011,6:271.
|
| [16] |
Janmaat ML, Gallegos-Ruiz MI, Rodriguez JA, et al. Predictive factors for outcome in a phase II study of gefitinib in secondline treatment of advanced esophageal cancer patients[J]. J Clin Oncol,2006, 24(10):1612-9.
|
| [17] |
Lyronis ID, Baritaki S, Bizakis I, et al. K-ras mutation, HPV infection and smoking or alcohol abuse positively correlate with esophageal squamous carcinoma[J]. Pathol Oncol Res, 20 08,14(3):267-73.
|
| [18] |
Sommerer F,Vieth M,Markwarth A,et al.Mutations of BRAF and KRAS2 in the development of Barrett’s adenocarcinoma[J]. Oncogene, 2004, 23(2):554-8.
|
| [19] |
Zhang HY,Zhang X,Chen X,et al.Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett’s esophagus[J]. Am J Physiol Gastrointest Liver Physiol, 2008,295(3):G470-8.
|
| [20] |
Blanco-Calvo M, Calvo L, Figueroa A, et al. Circulating microRNAs: molecular microsensors in gastrointestinal cancer[J]. Sensors (Basel), 2012,12(7):9349-62.
|
| [21] |
Kano M, Seki N, Kikkawa N, et al. miR-145, miR-133a and miR- 13 3b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma[J]. Int J Cancer, 2010, 127(12):2804-14.
|
| [22] |
Janmaat ML, Gallegos-Ruiz MI, Rodriguez JA, et al. Predictive factors for outcome in a phase II study of gefitinib in second-line treatment of advanced esophageal cancer patients[J]. J Clin Oncol, 20 06,24(10): 1612-9.
|
| [23] |
He B,You L,Uematsu K, et al.A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells[J]. Neoplasia, 20 04,6(1):7-14..
|
| [24] |
Choi YW, Heath EI, Heitmiller R, et al.Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas[J]. Mod Pathol, 2000,13(10):1055-9.
|
| [25] |
Clement G,Braunschweig R, Pasquier N, et al. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett’s oesophagus patients at risk for malignant transformation[J].J Pathol, 2006, 208(1):100-7.
|
| [26] |
Bian YS, Osterheld MC, Bosman FT, et al. Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus[J]. Am J Clin Pathol, 20 00,114(4):583-90.
|
| [27] |
Osterheld MC, Bian YS, Bosman FT, et al. Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus[J]. Am J Clin Pathol, 2002, 11 7(3):451-6.
|
| [28] |
Sierra J, Yoshida T, Joazeiro CA, et al. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes[J]. Genes Dev, 2006, 20(5):586-600.
|
| [29] |
Deng YZ, Chen PP, Wang Y, et al. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling[J]. J Biol Chem,2007,282(50):36571-81.
|
| [30] |
Wang JS, Ji AF, Wan HJ, et al. Gene silencing of β- catenin by RNAi inhibits proliferation of human esophageal cancer cells by inducing G0/G1 cell cycle arrest[J]. Asian Pac J Cancer Prev, 20 12, 13(6):2527-32.
|
| [31] |
Zhao BS, Liu SG, Qin XG. Expression of the Survivin and NF- κB in esophageal carcinoma tissue and its significance[J]. Yi Yao Chan Ye Zi Xun,2005,2(12):3-4.[ Ա , й , . Survivin NF-κB ʳ ܰ ֯ еı Ｐ [J].ҽҩ ҵ Ѷ,2005,2(12):3-4.]
|
| [32] |
Xia J, Wang F, Wang L, et al. Elevated serine protease HtrA1 inhibits cell proliferation, reduces invasion, and induces apoptosis in esophageal squamous cell carcinoma by blocking the nuclear factor-κB signaling pathway[J]. Tumour Biol, 2013, 34(1):317-28.
|
| [33] |
Tian F,Song M, Xu PR, et al. Effect of siRNA-mediated inhibition of nuclear factor-κB in combination with 5-FU on apoptosis of squamous cell carcinoma cell lines[J]. Shijie Hua Ren Xiao Hua Za Zhi,2008,16(16):1716-21.[ ﷼, , , .siRNA NF-κB ź ͨ· 5-FU ʳ ۰ ϸ Ĵٽ [J]. 绪 ־,2008,16(16):1716-21.]
|
| [34] |
Tian F, Song M, Xu PR, et al.Curcumin promotes apoptosis of esophageal squamous carcinoma cell lines through inhibition of NF-κB signaling pathway[J]. Ai Zheng,2008,27(6):566-70.[ ﷼, , , . NF-κB ź ͨ· ٽ ʳ ۰ ϸ о [J]. ֢,2008,27(6):566-70.]
|
| [35] |
Su CH,He YL,Ch e n ZG, e t a l .No t c h 1 e x p r e s s i o n i n esophageal squamous cell carcinoma and its relation with microvascular angiogenesis[J]. Nan Fang Yi Ke Da Xue Xue Bao,2009,29(11):2255-8. [ մ , ԣ¡, , . Notch1 ʳ ۰ еı Ｐ ëϸѪ Ĺ ϵ[J]. Ϸ ҽ ƴ ѧѧ ,2009,29(11):2255-8.]
|
| [36] |
Duan L,Yao J,Wu X,et al.Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells[J]. Biol Cell, 2006,98(8):479-90.
|
下载:
